Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1664 (LINC01664) is a human gene that encodes a long intergenic non-coding RNA (lincRNA), which is a subtype of long non-coding RNA (lncRNA) transcribed from regions of the genome that do not overlap known protein-coding genes. LincRNAs are typically longer than 200 nucleotides and are known for a variety of molecular regulatory roles, such as modulating chromatin structure, regulating transcription, and affecting gene expression, though most are incompletely characterized. There are currently no well-established biological functions, disease associations, or direct therapeutic relevance reported specifically for LINC01664, and it is not considered a therapeutic target or disease biomarker with known physiological or pharmacological activity. The primary value of this entry is for annotation and possible future study, as with the broader class of intergenic non-protein coding RNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1664 (LINC01664).